Probing the Molecular Mechanism of Cerium Oxide Nanoparticles in Protecting Against the Neuronal Cytotoxicity of Aß1-42 with Cu Ions
ISEF · 2015 Energy: Sustainable Materials and Design
Overview
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, which is characterized by the formation of senile plaques and neurofibrillary tangles in the brain. The pathological hallmark of AD is the cerebral amyloid beta peptide (Aß) deposits. The redox active metals involved in Aß peptides generally promote the aggregation of Aß peptides and produce reactive oxygen species (ROS) by Fenton-type and Harber-Weiss-type reactions, resulting in extensive impairment of cellular functions. Cerium oxide nanoparticles (CeO2NP), possess an astonishing pharmacological potential due to their antioxidant properties, deriving from a fraction of Ce3+ ions present in CeO2. Deriving from the Ce3+/Ce4+ ‘spontaneously’ recycle, CeO2NP has both superoxide dismutase (SOD) mimetic activity and catalase mimetic activity. By virtue to the ability of nanomaterials to cross the BBB, CeO2NP can be a promising candidate in the treatment of AD. The aim of this study is to probe the molecular mechanism for CeO2NP to protect against neural cytotoxicity from amyloid peptide and redox active metal ions. The systematic exploration of CeO2NP relieving AD related amyloid beta properties and neuronal cytotoxicity was carried out. Morphology of TEM revealed that CeO2NP may reduce Aß 1-42 aggregation. Cell viability assay indicated that CeO2NP protects neurotoxicity of Ab1-42 or Cu2+-Ab1-42 by scavenge ROS. CeO2NP can be administered in an amount sufficient to block production of hydroxyl or superoxide radicals, block free radical production or by Cu2+- Aß 1-42-induced ROS by Ce3+/Ce4+ catalytic cycles. All these results provide valuable insights into the molecular mechanism for CeO2NP as a therapeutic intervention to reduce oxidative and nitrosative damage.
Competition history
- ISEF 2015
Resources
Related projects
ISEF · 2024
Integrated in silico and in vitro Experimental Strategies for the Application of Carbon Quantum Dots in Alzheimer's Research
ISEF · 2016
Deciphering the Roles and Mechanism of Zn7MT3 in Abating Neuronal Cytotoxicity - Year Two
ISEF · 2014
Investigating the Effect of Polyhydroxylated Small-Gap Fullerene as an Antioxidant for Amyloidß-Induced Free Radicals in NT2 Cells
ISEF · 2014
Novel Analysis of Oxidative Stress and Inflammation on Amyloid-beta, Tau, and Motility in Transgenic C. elegans models: Targeting Potential Therapeutics for Alzheimer’s Disease
JSHS · 2025
Combating Alzheimer’s Disease: Design and Synthesis of a Novel Drug Molecule for Targeted Metal Chelation Therapy
ISEF · 2015
Repurposing CNI-1493 to Treat Alzheimer's Disease: Attenuation of Intracellular Amyloid Beta in vitro and in vivo
ISEF · 2025
Unlocking Neuroprotection: How Chebulinic Acid Targets Protein Biomarkers and Lipid Imbalance in Alzheimer's Disease
ISEF · 2022
Nano-Antioxidants' Effects on Oxidizing Agent Exposure
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair